Natco Pips Rivals To Launch Sovaldi Generics In Nepal
This article was originally published in PharmAsia News
Executive Summary
In a stunning move, last week Indian drug maker Natco launched generic copies of hepatitis C treatment Sovaldi in Nepal. The rollout signals a launch exercise in several other markets and may lead to an aggressive pricing battle between multiple Indian drug makers that signed licensing deals with Gilead.